GSK-4023991

N/A

Report date: 2025/03/20 14:49:59
NME

Base Information

Drug NameGSK-4023991
Drug Alias Namenucleoside reverse transcriptase translocation inhibitor (ViiV Healthcare)GSK-4023991
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNucleotide reverse transcriptase inhibitors
TargetsNucleotide reverse transcriptase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesViiv Healthcare Ltd
China Registration ClassN/A

Develop Information

Active CompaniesViiv Healthcare Ltd
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A